Owner Novartis AG

Inventors Zou, Bin; Ang, Shi Hua; Krastel, Philipp; Yeung, Bryan Ks; Tan, Liying Jocelyn; Wong, Wei Lin Josephine; Leong, Seh Yong

Agent Davies Collison Cave

Pub. Number AU-B-2009242279

PCT Pub. Number WO2009/132921

Priority 09151117.0 22.01.09 EP; 08155342.2 29.04.08 EP

Filing date 1 April 2009

Wipo publication date 5 November 2009

Acceptance publication date 30 August 2012

C07D 471/20 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/407 - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/424 - condensed with heterocyclic ring systems, e.g. clavulanic acid

A61K 31/437

A61K 31/438 - the ring being spiro-condensed with carbocyclic or heterocyclic ring systems

A61K 31/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 33/02 Antiparasitic agents

A61P 33/06 Antiparasitic agents

C07D 487/20 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 498/22 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms